A Role for Catecholamines in the Pathogenesis of Neuroleptic Malignant Syndrome
- 1 February 1986
- journal article
- research article
- Published by SAGE Publications in The Canadian Journal of Psychiatry
- Vol. 31 (1) , 66-69
- https://doi.org/10.1177/070674378603100114
Abstract
The authors present a case report in which an agitated response to antidepressants preceded the neuroleptic malignant syndrome (NMS). In a review of 64 cases of NMS in the literature, they found that 80% were described as agitated prior to the development of the syndrome. Polypharmacy was common. A review of the literature on theories of pathogenesis involving sympathetic amines other than dopamine is presented to explain this phenomena. It is suggested that these toxic reactions to medication can be interpreted as resulting from a relative NE/DA excess, in which antidepressants increase the numerator, while neuroleptics functionally decrease the denominator. It is recommended that where an agitated response to antidepressants is observed, neuroleptics should be used only with considerable caution.Keywords
This publication has 33 references indexed in Scilit:
- Atypical neuroleptic malignant syndrome responsive to conservative managementPsychosomatics, 1985
- Case report of neuroleptic malignant syndrome associated with withdrawal from amantadineAmerican Journal of Psychiatry, 1984
- Fatal hyperpyrexia after withdrawal of levodopaNeurology, 1984
- Neuroleptic Malignant SyndromeAnesthesia & Analgesia, 1983
- NEUROLEPTIC MALIGNANT SYNDROMEAustralian and New Zealand Journal of Medicine, 1983
- Acute Myoglobinuric Renal FailureArchives of internal medicine (1960), 1982
- Sympathoadrenomedullary hyperactivity in the neuroleptic malignant syndrome: a case reportAmerican Journal of Psychiatry, 1981
- Neuroleptic Malignant Syndrome-like State Following a Withdrawal of Antiparkinsonian DrugsJournal of Nervous & Mental Disease, 1981
- Neuroleptic malignant syndromeNeurology, 1981
- NeurolepticsPublished by American Medical Association (AMA) ,1978